Clinical Efficacy of Remicade in Chronic Beryllium Disease: A Randomized, Double-Blind, Placebo-Controlled, Investigator Initiated Trial.
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Infliximab (Primary)
- Indications Pneumoconiosis
- Focus Therapeutic Use
- Acronyms BISCIT
- 24 Sep 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 18 Feb 2009 New trial record